The ketogenic diet and epilepsy

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 11, Issue 2, 2008, Pages 113-120

  Kim, Do Young ^a   Rho, Jong M ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Ketogenic diet; Ketone bodies; Mitochondria; Neuroprotection; Oxidative stress; Polyunsaturated fatty acid

Indexed keywords

ACETONE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; KETONE BODY; POLYUNSATURATED FATTY ACID;

ANTICONVULSANT ACTIVITY; CALORIC RESTRICTION; EPILEPSY; EPILEPTOGENESIS; GLUCOSE UTILIZATION; GLYCOLYSIS; HUMAN; KETOGENESIS; KETOGENIC DIET; MITOCHONDRIAL RESPIRATION; NERVE CELL EXCITABILITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; REVIEW;

DIET, CARBOHYDRATE-RESTRICTED; EPILEPSY; HUMANS; ION CHANNELS; KETONE BODIES; KETOSIS; MITOCHONDRIAL PROTEINS; NERVOUS SYSTEM DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 40049107581     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3282f44c06     Document Type: Review

References (76)

1. Geyelin HR. Fasting as a method for treating epilepsy. Med Rec 1921; 99:1037-1039.
2. Wilder RM. The effect on ketonemia on the course of epilepsy. Mayo Clin Bull 1921; 2:307.
3. Kossoff EH, McGrogan JR, Bluml RM, et al. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 2006; 47:421-424.
4. Pfeifer HH, Thiele EA. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 2005; 65:1810-1812.
5. Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007; 48:43-58.
6. Morris AA. Cerebral ketone body metabolism. J Inherit Metab Dis 2005; 28:109-121.
7. Hartman AL, Gasior M, Vining EP, Rogawski MA. The neuropharmacology of the ketogenic diet. Pediatr Neurol 2007; 36:281-292.
8. Bough KJ, Wetherington J, Hassel B, et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol 2006; 60:223-235. This report demonstrates a direct correlation between the ketogenic diet and mitochondrial biogenesis in rat hippocampus. Hippocampal slices from ketogenic diet-treated animals better withstood metabolic stress due to preservation of ATP levels.
9. Pan JW, Bebin EM, Chu WJ, Hetherington HP. Ketosis and epilepsy: 31P spectroscopic imaging at 4.1 T. Epilepsia 1999; 40:703-707.
10. Klepper J, Diefenbach S, Kohlschütter A, Voit T. Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome. Prostaglandins Leukot Essent Fatty Acids 2004; 70:321-327.
11. Weber TA, Antognetti MR, Stacpoole PW. Caveats when considering ketogenic diets for the treatment of pyruvate dehydrogenase complex deficiency. J Pediatr 2001; 138:390-395.
12. Kang HC, Lee YM, Kim HD, et al. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia 2007; 48:82-88. This is one of very few clinical studies investigating the therapeutic role of the ketogenic diet in medically refractory epileptic patients known to have defects in MRC activity, and supports the role of the ketogenic diet against mitochondrial dysfunction-induced seizure activity.
13. Keith HM. Factors influencing experimentally produced convulsions. Arch Neurol Psych 1933; 29:148-154.
14. Rho JM, Anderson GD, Donevan SD, White HS. Acetoacetate, acetone, and dibenzylamine (a contaminant in L-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 2002; 43:358-361.
15. Likhodii SS, Burnham WM. On the anticonvulsant effect of acetone and the ketogenic diet. Epilepsia 2002; 43:1596-1597.
16. Likhodii SS, Serbanescu I, Cortez MA, et al. Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann Neurol 2003; 54:219-226.
17. Seymour KJ, Bluml S, Sutherling J, et al. Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet. Magma 1999; 8:33-42.
18. Fraser DD, Whiting S, Andrew RD, et al. Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology 2003; 60:1026-1029.
19. Dahlin M, Hjelte L, Nilsson S, Amark P. Plasma phospholipids fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy. Epilepsy Res 2007; 73:199-207. This is one of few clinical reports investigating the role of fatty acids in the human epileptic patients. These results contrast that of another previous study [34].
20. Sullivan PG, Rippy NA, Dorenbos K, et al. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol 2004; 55:576-580.
21. Likhodii SS, Burnham WM. Ketogenic diet: does acetone stop seizures? Med Sci Monit 2002; 8:HY19-HY24.
22. Pan JW, Rothman TL, Behar KL, et al. Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis. J Cereb Blood Flow Metab 2000; 20:1502-1507.
23. Nordli DR Jr, De Vivo DC. The ketogenic diet revisited: back to the future. Epilepsia 1997; 38:743-749.
24. Bough KJ, Paquet M, Pare JF, et al. Evidence against enhanced glutamate transport in the anticonvulsant mechanism of the ketogenic diet. Epilepsy Res 2007; 74:232-236.
25. Nylen K, Likhodii SS, Hum KM, Burnham WM. A ketogenic diet and diallyl sulfide do not elevate afterdischarge thresholds in adult kindled rats. Epilepsy Res 2006; 71:23-31.
26. Noh HS, Kim DW, Kang SS, et al. Ketogenic diet prevents clusterin accumulation induced by kainic acid in the hippocampus of male ICR mice. Brain Res 2005; 1042:114-118.
27. Yudkoff M, Daikhin Y, Nissim I, et al. Short-term fasting, seizure control and brain amino acid metabolism. Neurochem Int 2006; 48:650-656.
28. Levin BE. Metabolic sensors: viewing glucosensing neurons from a broader perspective. Physiol Behav 2002; 76:397-401.
29. Ma W, Berg J, Yellen G. Ketogenic diet metabolites reduce firing in central neurons by opening K(ATP) channels. J Neurosci 2007; 27:3618-3625. This study demonstrated for the first time that BHB and ACA reduce spontaneous firing of GABAergic neurons in the substantia nigra pars reticulata, an effect that is linked to opening of ATP-sensitive potassium channels.
30. Tieu K, Perier C, Caspersen C, et al. D-beta- Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J Clin Invest 2003; 112:892-901.
31. Noh HS, Lee HP, Kim DW, et al. A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Brain Res Mol Brain Res 2004; 129:80-87.
32. Garriga-Canut M, Schoenike B, Qazi R, et al. 2-Deoxy-D- glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat Neurosci 2006; 9:1382-1387. These investigators showed that 2-deoxyglucose, an inhibitor of a glycolytic enzyme, suppressed epileptogenesis in the rat kindling model, strongly supporting the hypothesis that glucose restriction may produce anticonvulsant effects.
33. Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005; 112:2762-2768.
34. Leaf A, Xiao YF, Kang JX, Billman GE. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Pharmacol Ther 2003; 98:355-377.
35. Xiao YF, Wright SN, Wang GK, et al. Fatty acids suppress voltage-gated Na+ currents in HEK293t cells transfected with the alpha-subunit of the human cardiac Na+ channel. Proc Natl Acad Sci U S A 1998; 95:2680-2685.
36. Xiao YF, Gomez AM, Morgan JP, et al. Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A 1997; 94:4182-4187.
37. Vreugdenhil M, Bruehl C, Voskuyl RA, et al. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci U S A 1996; 93:12559-12563.
38. Cunnane SC, Musa K, Ryan MA, et al. Potential role of polyunsaturates in seizure protection achieved with the ketogenic diet. Prostaglandins Leukot Essent Fatty Acids 2002; 67:131-135.
39. Taha AY, Ryan MA, Cunnane SC. Despite transient ketosis, the classic high-fat ketogenic diet induces marked changes in fatty acid metabolism in rats. Metabolism 2005; 54:1127-1132.
40. Dekaban AS. Plasma lipids in epileptic children treated with the high fat diet. Arch Neurol 1966; 15:177-184.
41. Rabinovitz S, Mostofsky DI, Yehuda S. Anticonvulsant efficiency, behavioral performance and cortisol levels: a comparison of carbamazepine (CBZ) and a fatty acid compound (SR-3). Psychoneuroendocrinology 2004; 29:113-124.
42. Voskuyl RA, Vreugdenhil M, Kang JX, Leaf A. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol 1998; 341:145-152.
43. Taha AY, Baghiu BM, Lui R, et al. Lack of benefit of linoleic and alpha-linolenic polyunsaturated fatty acids on seizure latency, duration, severity or incidence in rats. Epilepsy Res 2006; 71:40-46.
44. Yehuda S, Carasso RL, Mostofsky DI. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 1994; 254:193-198.
45. Schlanger S, Shinitzky M, Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 2002; 43:103-104.
46. Yuen AW, Sander JW. Is omega-3 fatty acid deficiency a factor contributing to refractory seizures and SUDEP? A hypothesis. Seizure 2004; 13:104-107.
47. Yuen AW, Sander JW, Fluegel D, et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav 2005; 7:253-258.
48. Marszalek JR, Lodish HF. Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you. Annu Rev Cell Dev Biol 2005; 21:633-657.
49. Glomset JA. Role of docosahexaenoic acid in neuronal plasma membranes. Sci STKE 2006; 321:e6.
50. Lim GP, Calon F, Morihara T, et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 2005; 25:3032-3040.
51. Cole GM, Lim GP, Yang F, et al. Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic antioxidant interventions. Neurobiol Aging 2005; 26(Suppl 1):133-136.
52. Kotani S, Sakaguchi E, Warashina S, et al. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res 2006; 56:159-164.
53. Bazan NG. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol 2005; 15:159-166.
54. Hashimoto M, Tanabe Y, Fujii Y, et al. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 2005; 135:549-555.
55. Montine TJ, Morrow JD. Fatty acid oxidation in the pathogenesis of Alzheimer's disease. Am J Pathol 2005; 166:1283-1289.
56. Reger MA, Henderson ST, Hale C, et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 2004; 25:311-314.
57. Farasat S, Kossoff EH, Pillas DJ, et al. The importance of parental expectations of cognitive improvement for their children with epilepsy prior to starting the ketogenic diet. Epilepsy Behav 2006; 8:406-410.
58. Henshall DC, Chen J, Simon RP. Involvement of caspase-3-like protease in the mechanism of cell death following focally evoked limbic seizures. J Neurochem 2000; 74:1215-1223.
59. Henshall DC, Bonislawski DP, Skradski SL, et al. Cleavage of bid may amplify caspase-8-induced neuronal death following focally evoked limbic seizures. Neurobiol Dis 2001; 8:568-580.
60. Kubova H, Druga R, Lukasiuk K, et al. Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats. J Neurosci 2001; 21:3593-3599.
61. Kudin AP, Kudina TA, Seyfried J, et al. Seizure-dependent modulation of mitochondrial oxidative phosphorylation in rat hippocampus. Eur J Neurosci 2002; 15:1105-1114.
62. Kunz WS, Kudin AP, Vielhaber S, et al. Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann Neurol 2000; 48:766-773.
63. Noh HS, Kim YS, Lee HP, et al. The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res 2003; 53:119-128.
64. Walton NY, Nagy AK, Treiman DM. Altered residual ATP content in rat brain cortex subcellular fractions following status epilepticus induced by lithium and pilocarpine. J Mol Neurosci 1998; 11:233-242.
65. Kim DY, Davis LM, Sullivan PG, et al. Ketone bodies are protective against oxidative stress in neocortical neurons. J Neurochem 2007; 101:1316-1326. This paper demonstrates that ketone bodies can prevent hydrogen peroxideinduced neuronal injury in neocortical neurons, by suppressing mitochondrial ROS generation.
66. Maalouf M, Sullivan PG, Davis L, et al. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 2007; 145:256-264. This is a demonstration that ketone bodies inhibit glutamate-induced neuronal injury in neocortical neurons, and that this neuroprotective effect is associated with decreased mitochondrial ROS generation through enhanced NADH oxidation.
67. Masuda R, Monahan JW, Kashiwaya Y. D-beta-Hydroxybutyrate is neuroprotective against hypoxia in serum-free hippocampal primary cultures. J Neurosci Res 2005; 80:501-509.
68. Zhao Z, Lange DJ, Voustianiouk A, et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 2006; 7:29.
69. Imamura K, Takeshima T, Kashiwaya Y, et al. D-beta-Hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease. J Neurosci Res 2006; 84:1376-1384. This study demonstrated that D-β-hydroxybutyrate can rescue dopaminergic neurons against the damaging effects of a MRC I inhibitor.
70. Heinemann U, Konnerth A, Pumain R, Wadman WJ. Extracellular calcium and potassium concentration changes in chronic epileptic brain tissue. Adv Neurol 1986; 44:641-661.
71. Kovacs R, Schuchmann S, Gabriel S, et al. Free radical-mediated cell damage after experimental status epilepticus in hippocampal slice cultures. J Neurophysiol 2002; 88:2909-2918.
72. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta 1995; 1241:139-176.
73. Krieger C, Duchen MR. Mitochondria, Ca2+ and neurodegenerative disease. Eur J Pharmacol 2002; 447:177-188.
74. Votyakova TV, Reynolds IJ. DeltaPsi(m)-dependent and -independent production of reactive oxygen species by rat brain mitochondria. J Neurochem 2001; 79:266-277.
75. Diano S, Matthews RT, Patrylo P, et al. Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology 2003; 144:5014-5021.
76. Sullivan PG, Dube C, Dorenbos K, et al. Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann Neurol 2003; 53:711-717.